Skip to content

Digital Oximetry DOX technology to measure blood oxygen saturation SpO2.

A prospective clinical investigation to evaluate SpO2 sensor performance in adult, pediatric and neonatal populations. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/04/107986
Enrollment
25
Registered
2026-04-09
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: Z008- Encounter for other general examination

Interventions

Intervention1: Primary device under test DOX SpO2 Module and SpO2 Sensor Actual device: Patient monitor with DOX SpO2 Module: Each subject will undergo a series of standardized test scenarios where

Sponsors

Criticare Technologies Inc.
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Adults greater or equal to 22 years 2 Pediatric less than 22 years Neonates from birth through the first 28 days of life Infants 29 days to less than 2 years Children 2 years to less than 12 years Adolescents aged 12 through 21 years up to but not including 22 years 3 Informed consent from adult participants or guardians for minors 4 Representation across Monk Skin Tone classification scale.

Exclusion criteria

Exclusion criteria: 1 Poor peripheral perfusion due to underlying disease. 2 Current use of vasoactive drugs. 3 Inability to tolerate sensor placement or procedures.

Design outcomes

Primary

MeasureTime frame
1.Overall accuracy of SpO2 sensor will be compared with a validated reference pulse oximeter across adult, pediatric and neonatal subjects. 2.SpO2 measurements under normoxia - Accuracy of SpO2 readings under normoxic condition 3. Effect of skin tone - Evaluation of sensor performance (measurement accuracy) across a range of skin tones, assessed using the Monk Skin Tone (MST) scale.Timepoint: Screening prior to enrollment Baseline after informed consent SpO2 recorded at 15 second intervals during normoxia three readings motion phase for 2 minutes and low perfusion phase up to 5 minutes or observational in neonates All assessments performed during a single visit

Secondary

MeasureTime frame
1. SpO2 sensor performance under motion: - Stability & continuity of SpO2 readings during rhythmic movements (e.g., arm tapping & hand raising). - Comparison of sensor accuracy & signal quality with reference device under motion artifacts. 2. SpO2 sensor performance under low perfusion: - Accuracy of SpO2 readings under reduced perfusion (e.g., cold-induced or vascular restriction via cuff). - Evaluation of signal consistency & comparison to reference pulse oximeter.Timepoint: Screening prior to enrollment Baseline after informed consent SpO2 recorded at 15 second intervals during normoxia three readings motion phase for 2 minutes & low perfusion phase up to 5 minutes or observational in neonates All assessments performed during a single visit

Countries

India

Contacts

Public ContactDr W D Mohan

Sagar Hospitals, Jayanagar, Bengaluru

drwdm96@gmail.com919538352116

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026